Member Profile
Dr Marina Cerbo
- Agency:
- Agenas (COTE)
- Job Title:
- Chief of Innovation, Research and Development Depa
- Organisation:
- Agenzia Nationale per I Servizi Sanitari Regionali
- Tel:
- +39 06 42749304/5
- Fax:
- +39 06 42749325
- Email:
- cerbo@agenas.it
-
Website:
- www.agenas.it
- Address:
-
Via Puglie 23, 00187 Rome, Italy
- Agency Member Since:
- 01/3/2009
- Additional Contacts:
- Maria Rosaria Perrini
- EAAS Name:
- Centre for the Observation of Emerging Health Technologies (COTE)
- EAAS Host Organisation:
- Age.na.s
- Country and/or Region:
- Italy
- Year EAAS formally established:
- 2008
- EAAS Status:
- Pilot
- EAAS Main Output Language:
- Italian and English
- EAAS Description:
- Our EAAS aims to support, with scientific evidence, the introduction of new and emerging technologies in the health system, providing a permanent system of useful information to decision makers. The objectives are to promote evidence based innovation at different local levels and develop capabilities in evaluation and decision making. The source of funding is 100% public, by government (Ministry of Labour, Healthcare and Social Policy). Our main customers are: institutional decision makers, to support policy linked to new technologies; healthcare professionals, to support clinical practice; researchers, to generate evidence on new and emerging technologies. Main outputs are the production of HS reports and an Italian Model for Horizon scanning.
- Main source of funding:
- National health system - Department of Health or health services
- Purpose of EAAS:
-
- To inform decisions on coverage or reimbursement of health services
- Types of technologies covered by EAAS:
-
- Devices (including imaging equipment)
- Diagnostics (diagnostic and prognostic biomarkers)
- Interventional procedures (e.g. surgery)
- Health care settings (e.g. organisational changes, professional boundaries)
- Main customers of EAAS:
-
- National Government Health Departments & Ministers
- Regional, State or Provincial Government
- Health services purchasers, commissioners or other decision makers
- Health care providers e.g. hospitals
- Health care professionals, medical advisors or clinical experts
- National research & development programme
- Contents of Main Output from EAAS:
-
- Potential for significant health service impact
- Safety and efficacy
- Assessment of clinical effectiveness